← Insider buys
BMY

Bristol-Myers Squibb Company · Healthcare

Board Chair, CEO Giovanni Caforio sold $17.9M of Bristol-Myers Squibb Company

Sold$17,916,000
$74.65Price
240,000Shares
−50%Stake

What BMY did after the filing

Filed Feb 8Copier in Feb 9
The stock from Thu, Feb 9 open, $63.44
−7.9%
S&P 500, same days
−4.1%

Measured over 30 trading days, to the Mar 24 close.

Traded Mon, Feb 6. Filed Wed, Feb 8, 8:09 PM ET, after the close. Returns use the Feb 9 open and the Mar 24 close. Not investment advice.